Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-20-032794

General Counsel sold 322 shares at $3.62 ($1,166)

  • General Counsel acquired 892 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
DENYES NANCY General Counsel 2020-05-16 Option exercise +892 3,057 D
DENYES NANCY General Counsel 2020-05-20 Sale −322 $3.62 $1,166 2,735 D
Derivatives
DENYES NANCY General Counsel 2020-05-26 Grant or award · Employee Stock Option (right to buy) +30,000 30,000 D
DENYES NANCY General Counsel 2020-05-16 Option exercise · Restricted Stock Unit −892 0 D
Open-market sales · 322 sh · avg $3.62 · $1,166
Loading xslF345X03/doc4.xml…